Insider Trading History of Johann Peter

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Johann Peter since 2006. The trader's CIK number is 1369942. At the time of the last reporting, Johann Peter was the Director of Horizon Therapeutics Public Ltd Co. (stock ticker symbol HZNP). Also see all insider trading activities at Horizon Therapeutics Public Ltd Co.

Note that in the past Johann Peter also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Cancervax Corp (MITI) by Johann Peter

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 MITI 5,000 $25,400 0 $0 0 $0
2008 MITI 129,413 $544,828 0 $0 0 $0
2007 MITI 913,265 $2,452,832 0 $0 0 $0
2006 MITI 2,222,222 $7,999,999 0 $0 0 $0

Yearly summary of insider trading at Horizon Therapeutics Public Ltd Co (HZNP) by Johann Peter

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 HZNP 194,639 $1,751,751 0 $0 0 $0


Insider trading activities at 2 companies by Johann Peter:

1. Cancervax Corp (MITI)

2. Horizon Therapeutics Public Ltd Co (HZNP)

Table 1. Insider trading of Cancervax Corp (MITI) by Johann Peter

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-03-16 MITI Buy 5,000 5.08 25,400
2008-10-02 MITI Buy 129,413 4.21 544,828
2007-08-20 MITI Buy 5,000 1.92 9,600
2007-06-22 MITI Buy 908,265 2.69 2,443,232
2006-07-24 MITI Buy 2,222,222 3.60 7,999,999

Table 2. Insider trading of Horizon Therapeutics Public Ltd Co (HZNP) by Johann Peter

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-08-02 HZNP Buy 194,639 9.00 1,751,751

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Johann Peter (Director of Horizon Therapeutics Public Ltd Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.